US

Kiran P Amancha

This inventor holds 0 USPTO granted patents, plus 2 CIPO patents.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Kiran P Amancha. Retrieved from https://idiyas.com/inventor/kiran-p-amancha-rpiroabd

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
 

Average Co-Inventor Count = 1.0

ph-index = 1


Loading Chart...

Title: Kiran P Amancha: Innovator in Pain Management Solutions

Introduction

Kiran P Amancha is an inventive mind based in the United States, known for his contributions to the field of pharmaceutical formulations. His work primarily focuses on developing innovative solutions for pain management and opioid dependence.

Latest Patents

Kiran P Amancha holds a notable invention titled "Sublingual Buprenorphine Spray." This invention provides sublingual formulations containing buprenorphine, a pharmaceutically acceptable salt thereof, or a derivative thereof. Additionally, it includes formulations that combine buprenorphine and naloxone, along with their pharmaceutically acceptable salts or derivatives. The invention also outlines a method for treating pain or opioid dependence by administering these sublingual formulations to patients in need.

Career Highlights

Kiran P Amancha is associated with Benuvia Therapeutics LLC, where he continues to work on advancing therapeutic solutions. His innovative approach to drug formulation has the potential to significantly impact the treatment of pain and opioid dependence.

Collaborations

Some of his notable coworkers include Chandeshwari S Chilampalli and Venkat R Goskonda, who contribute to the collaborative efforts at Benuvia Therapeutics LLC.

Conclusion

Kiran P Amancha's work in developing sublingual formulations represents a significant advancement in pain management and opioid dependence treatment. His innovative contributions are paving the way for more effective therapeutic options.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…